Corporate Banner
Satellite Banner
Genotyping & Gene Expression
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Population Genetics Launches Funding Award for Novel Population Sequencing Studies

Published: Monday, October 15, 2012
Last Updated: Monday, October 15, 2012
Bookmark and Share
The Populus Award 2012 offers financial and expert practical support for the completion of a multi-sample gene sequencing project.

Population Genetics Technologies Ltd. has today launched the Populus Award 2012. Inviting abstracts from researchers undertaking a range of population genetics studies, the award will provide the successful applicant with funding and practical support for their sequencing study, as well as access to the extensive expertise and proprietary technologies provided by Population Genetics. These technologies have the power to increase the efficiency and accuracy of next generation sequencing (NGS) studies, allowing researchers to reliably link genotypic variation with phenotype. Other applicants will also have the chance to benefit from the award, receiving collaborative advice and input from the experts at Population Genetics to help them to further advance their research projects.

Dr. Frank Massam, Chief Commercial Officer, Population Genetics, commented: “The Populus Award 2012 provides an ideal opportunity for a research group with limited funds or experience to gain access to the latest technological and practical expertise in the field. Using our proprietary approaches and funding support, we will enable them to accurately sequence either genomic regions of interest or indeed, whole genes in large populations of samples, providing the next leap in sequencing analysis.”

For the successful applicant, Population Genetics will use its established approach to sequence their samples using the NGS platform of their choice. An innovative molecular tagging system enables the accurate sequencing of either multiple non-contiguous or long, contiguous regions from many thousands of samples, in a single experiment. This allows researchers to confidently identify genetic variants attributed to a specific phenotype. Such high quality data is significantly valuable in areas such as human healthcare, as it mediates the rapid discovery of gene variants characteristic of a particular disorder or a specific drug response, facilitating the development of informed, personalised treatment strategies.

Applications must be submitted online by the 30th of November 2012. The successful applicant will be announced in January 2013.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Population Genetics Collaborates with Cambridge University to Unravel the Genetic Causes of Asperger Syndrome
Joint study aims to identify sequence variants in two genes, both of which have been previously associated with Asperger Syndrome.
Monday, July 09, 2012
Dr Alan Schafer to head Population Genetics as CEO
Schafer brings deep experience in research, “big pharma” management and building new businesses.
Thursday, May 03, 2012
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Drug - Gene 'One-Two' Punch Against Cancer
Researchers identify gene-drug combinations that, together, target and kill cancer cells while not targeting healthy cells.
Drug Candidates Reduce Abnormal Protein Production
New drug candidates improve cell ability to catch miss-folded proteins that could cause deadly diseases.
Diagnostic Thread - Weaving the Future?
Researchers have created diagnostic threads that could pave the way for next-gen implantable and wearable diagnostics.
Unravelling the Roots of Insect’s Waterproof Coating
Researchers have identified the genes that control cuticular lipid production in Drosophila, by performing an RNAi screen and using Direct Analysis in Real Time and GC-MS.
RNA Suppresses Inflammation
Researchers identify a long noncoding RNA that regulates innate immunity.
Competition to Decipher RNA-Cancer Link
DREAM challenge aims to find the best algorithms for detecting abnormal RNA molecules in cancer cells.
Red Hair Gene Increases Cancer Mutations
Red hair gene variant drives up skin cancer mutations equivalent to that expected from 21 years of sun exposure.
Type 2 Diabetes Genetics Revealed
The largest study of its kind into type 2 diabetes has produced the most detailed picture to date of the genetics underlying the condition.
Blood Cancer Could be Prevented Before it Develops
New research suggests myeloma could be prevented before it develops out of symptomless condition in bone marrow.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!